TickerFactsScreenerDevelopers

Cytosorbents Corp (CTSO) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $3.95M2017: $5.52M2018: $7.49M2019: $7.36M2020: $11.05M2021: $11.05M2022: $13.96M2023: $9.13M2024: $10.71M2025: $10.57M$10.57M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$10.57M-1.3%
2024$10.71M+17.3%
2023$9.13M-34.6%
2022$13.96M+26.3%
2021$11.05M-0.0%
2020$11.05M+50.1%
2019$7.36M-1.7%
2018$7.49M+35.7%
2017$5.52M+39.6%
2016$3.95M—